
GlaxoSmithKline posted a 4% slide in revenue for the second quarter today as its recovery from a slew of patent …

The Royal College of Nursing says that whilst a new wireless diagnostic patch is certainly innovative, they are concerned that …

Two big-name oncology brands, Bristol-Myers Squibb’s Yervoy and Astellas Pharma’s Xtandi, have been given the nod by drug costs watchdog …

Clinical diagnostics firm Agena Bioscience has confirmed that Peter Dansky has joined the company as its chief executive and will …

Allergan is to cut 1,500 jobs as part of a restructure which it believes will make pre-tax savings of around …

AZ’s MedImmune has entered into a clinical trial collaboration with US biotech firm Advaxis to help develop new cancer immunotherapies. …

UK researchers are to gain access to compounds from seven pharma companies in a partnership with the Medical Research Council …

Healthcare research agency Cello Health Insight has made two director-level appointments on the back of a wave of new hires.

Patients with HIV and hepatitis C virus (HCV) have responded well to a combination of Gilead Sciences’ Sovaldi and ribavirin …
The advent of social media sites such as Twitter and Facebook are fuelling complaints about doctors, according to a new …
Just prior to landing in San Diego it was somewhat disconcerting to see fire spreading across the terrain and huge …

AstraZeneca’s new international HQ on the Cambridge Biomedical Campus (CBC), due to open in two years’ time, will feature an …

California-based speciality pharma firm Depomed has appointed Dr Srinivas Rao as its chief medical officer (CMO) and senior VP. Rao …

Shire has accepted a £32 billion takeover deal from AbbVie after months of rejections and uncertainty. The firm, which is …
GlaxoSmithKline’s new combination melanoma treatment has bested Roche’s established oncology drug Zelboraf when treating patients with the deadliest form of …
A Phase II clinical trial for Genentech’s investigational Alzheimer’s drug failed to meet its primary endpoints – but the company …

Pfizer is to pay as much as $360 million for private pharma development company InnoPharma in a financial arrangement comprising …

James Davis has been elected chairman of the national board of directors of The Leukemia & Lymphoma Society (LLS). Davis …

Johnson & Johnson saw sales rise 9.1% to $19.5 billion year on year on the back of a strong performance …

Bayer Healthcare has appointed Malini Moorthy to head up its litigation department in the US. Moorthy joins the German firm from …